Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
מצבים רפואיים
Soft Tissue Sarcoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Mayo Clinic Arizona, Phoenix, Arizona, United States
Contact: Principal Investigator (Mahesh Seetharam, MD)USC Norris comprehensive cancer center, Los Angeles, California, United States
Contact: Principal Investigator (Mark Agulnik, M.D)Stanford University Medical Centre, Palo Alto, California, United States
Contact: Principal Investigator (Nam Bui, MD)UCSF, San Francisco, California, United States
Contact: Principal Investigator (Varun Monga, M.D)UCLA, Santa Monica, California, United States
Contact: Principal Investigator (Arun Singh, M.D)University of Colorado Cancer Center/ CU Anschutz Medical Campus, Aurora, Colorado, United States
Contact: Principal Investigator (Breelyn Wilky, MD)Mayo Clinic Florida, Jacksonville, Florida, United States
Contact: Principal Investigator (Steven Attia, DO)University of Miami/ Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Contact: Principal Investigator (Emily Jonczak, MD)Moffitt Cancer Center, Tampa, Florida, United States
Contact: Principal Investigator (Mihaela Druta, MD)Northwestern, Chicago, Illinois, United States
Contact: Principal Investigator (Seth Pollack, MD)Indiana University, Indianapolis, Indiana, United States
Contact: Principal Investigator (Samantha Armstrong, MD)University of Iowa, Iowa City, Iowa, United States
Mass General Brigham Cancer Center, Boston, Massachusetts, United States
Contact: Principal Investigator (Edwin Choy, M.D)University of Michigan, Ann Arbor, Michigan, United States
Contact: Principal Investigator (Rashmi Chugh, MD)Mayo Clinic Rochester, Rochester, Minnesota, United States
Contact: Principal Investigator (Brittany Siontis, M.D)Washington University School of Medicine - Siteman Cancer Center, St Louis, Missouri, United States
Contact: Principal Investigator (Brian Van Tine, MD)NYU Langone Health, New York, New York, United States
Contact: Principal Investigator (Matthew Ingham, MD)Columbia University, New York, New York, United States
Contact: Principal Investigator (Igor Matushansky, M.D.Ph.D)Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Principal Investigator (Viswatej Avutu, MD)Duke Cancer Institute, Durham, North Carolina, United States
Contact: Principal Investigator (Juneko Grilley-Olson, MD)University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
Contact: Principal Investigator (Ankit Mangla, MD)Ohio State University Wexner Medical Center/ The James Cancer Hospital and Solove Research Institute, Columbus, Ohio, United States
Contact: Principal Investigator (David Liebner, MD)UPenn (Abramson Cancer Center, Pennsylvania Hospital), Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Lee Hartner, MD)UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Melissa Burgess, M.D)University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (John A Livingston, MD)Medical College of Wisconsin/ Froedtert Hospital, Milwaukee, Wisconsin, United States
Contact: Principal Investigator (John Charlson, MD)UHN - Princess Margaret Cancer Center (Ontario), Toronto, Ontario, Canada
Contact: Principal Investigator (Albiruni Razak, MB BCh)McGill University Health Centre (Quebec), Montreal, Quebec, Canada
Contact: Principal Investigator (Ramy Saleh, MD)Chang Gung Medical Foundation Kaohsiung, Kaohsiung City, Niaosong District, Taiwan
Contact: Principal Investigator (Yu-Li Su, MD)National Taiwan University Hospital, Taipei, Taipei, Taiwan
Contact: Principal Investigator (Wei-Wu (Tom) Chen, MD)Taipei Veterans General Hospital, Taipei, Taipei, Taiwan
Contact: Principal Investigator (Chueh-Chuan Yen)
מובילי המחקר
John S Bomalaski
Study Director
Polaris Group